MoneyWorks4Me

Auro Laboratories - Quaterly Results

02 Aug 2022 Evaluate
The June 2022 quarter revenue stood at Rs. 111.85 millions, up 6.22% as compared to Rs. 105.30 millions during the corresponding quarter last year.A big loss of -92.21% reported for the quarter ended June 2022 to Rs. 0.83  millions from Rs. 10.66 millions.Operating Profit reported a sharp decline to 6.27 millions from 18.75 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 111.85 105.30 6.22 111.85 105.30 6.22 508.66 542.52 -6.24
Other Income 0.51 4.95 -89.70 0.51 4.95 -89.70 10.92 7.58 44.06
PBIDT 6.27 18.75 -66.56 6.27 18.75 -66.56 57.17 120.00 -52.36
Interest 2.62 1.11 136.04 2.62 1.11 136.04 8.26 4.58 80.35
PBDT 3.65 17.64 -79.31 3.65 17.64 -79.31 48.91 115.42 -57.62
Depreciation 2.50 2.60 -3.85 2.50 2.60 -3.85 10.17 10.36 -1.83
PBT 1.15 15.04 -92.35 1.15 15.04 -92.35 38.74 105.06 -63.13
TAX 0.32 4.38 -92.69 0.32 4.38 -92.69 10.29 33.26 -69.06
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 1.25 -130.40
PAT 0.83 10.66 -92.21 0.83 10.66 -92.21 28.45 71.80 -60.38
Equity 62.33 62.33 0.00 62.33 62.33 0.00 62.32 62.32 0.00
PBIDTM(%) 5.61 17.81 -68.52 5.61 17.81 -68.52 11.24 22.12 -49.19
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..